EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in resistance mechanisms and counterstrategies for antibody‑drug conjugates in HER2‑low and HER2‑ultralow breast cancer (Review)

Xiaojie Yu, Meilin Ren, Longdi Yao

Oncology Reports · 20.10.2026 · 56 (6) · 1-15

DOI: 10.3892/or.2026.9214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 20.10.2026. Verfasst von Xiaojie Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu 225000, P.R. China. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Drug Resistance, Neoplasm, Immunoconjugates. Die Arbeit nennt 104 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesDrug Resistance, NeoplasmImmunoconjugatesAntineoplastic Agents, ImmunologicalHumansFemaleTrastuzumabBiomarkers, Tumor

Stichwörter der Autor:innen

HER2‑ultralowantibody‑drug conjugatesbreast cancerhuman epidermal growth factor receptor (HER)2‑lowresistance mechanisms

Substanzen

Erb-b2 Receptor Tyrosine KinasesImmunoconjugatesERBB2 protein, humanAntineoplastic Agents, ImmunologicalTrastuzumabBiomarkers, Tumor

Autor:innen und Institutionen

  • Clinical Medical College, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu 225000, P.R. China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei 050000, P.R. China.
  • Department of Thyroid and Breast Surgery, Changxing Hospital of Traditional Chinese Medicine, Huzhou, Zhejiang 313000, P.R. China.

Zitieren

APA

Yu, X., Ren, M., & Yao, L. (2026). Advances in resistance mechanisms and counterstrategies for antibody‑drug conjugates in HER2‑low and HER2‑ultralow breast cancer (Review). Oncology Reports, 56(6), 1-15. https://doi.org/10.3892/or.2026.9214

Vancouver

Yu X, Ren M, Yao L. Advances in resistance mechanisms and counterstrategies for antibody‑drug conjugates in HER2‑low and HER2‑ultralow breast cancer (Review). Oncology Reports. 2026;56(6):1-15. doi:10.3892/or.2026.9214

BibTeX
@article{Yu2026,
  author = {Yu, Xiaojie and Ren, Meilin and Yao, Longdi},
  title = {Advances in resistance mechanisms and counterstrategies for antibody‑drug conjugates in HER2‑low and HER2‑ultralow breast cancer (Review)},
  journal = {Oncology Reports},
  year = {2026},
  volume = {56},
  number = {6},
  pages = {1--15},
  doi = {10.3892/or.2026.9214}
}
Kostenlos starten →